The move will give 95 lower-income countries access to a generic version of Pfizer’s oral Covid-19 antiviral treatment.
Subscribe to:
Post Comments (Atom)
< + > Beyond the Science by Gary Zammit – Life Sciences Today Podcast Episode 46
We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Gary Zammit, PhD,...
No comments:
Post a Comment